
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has had a solid quarter, benefiting from healthy growth in Asia and a strong performance in wealth management. Although there are concerns stemming from a recent tax announced by the Chinese government that could impact its products for mainland Chinese residents, experts remain cautiously optimistic about MFC's long-term prospects. Many analysts highlight the company's consistent dividend yield, which is seen as attractive amidst the uncertainty in the market. Some investors recommend waiting for a market pullback before making new purchases, emphasizing that MFC is currently overbought. The general sentiment suggests that while MFC has a strong story, careful selection and timing will be pivotal for future gains.
Cheaper PE at 8.5x than peers, decent growth rate of 9%. Nice beat recently with Asia up 21%, EPS up 18%, ROE starting to get higher at 16.7%. Helped by rates being higher for longer. Insurance companies still better than the banks, and fund flows continue. Nice yield of 4.5%, with 8% growth.
Ideally, he'd like to buy lower. But can still buy here and it will work for your portfolio over the next 1-2 years.
Debating quality of company within investment team. Sees money coming out of financial sector in Canada - going into insurance companies. Not overly positive on direction of business. If expectations for rate cuts continues - will be good for business. Would recommend investors to hold the position.
De-risked US business, the weakest unit. He's looking at it, on shopping list, hasn't yet pulled trigger. Re-rated nicely, undemanding multiple, single-digit PE ratio. Yield is ~4%. Pay attention to chart validating fundamental changes, often a leading indicator of changes within. Wouldn't quarrel with investors taking a position.